0001209191-21-002948.txt : 20210111
0001209191-21-002948.hdr.sgml : 20210111
20210111164404
ACCESSION NUMBER: 0001209191-21-002948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201211
FILED AS OF DATE: 20210111
DATE AS OF CHANGE: 20210111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glickman Richard M
CENTRAL INDEX KEY: 0001352637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37410
FILM NUMBER: 21521282
MAIL ADDRESS:
STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION
STREET 2: 1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: V8Z7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ESSA Pharma Inc.
CENTRAL INDEX KEY: 0001633932
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
BUSINESS PHONE: (778) 331-0962
MAIL ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-11
0
0001633932
ESSA Pharma Inc.
EPIX
0001352637
Glickman Richard M
C/O ESSA PHARMA INC.
999 WEST BROADWAY, SUITE 720
VANCOUVER
A1
V5Z 1K5
BRITISH COLUMBIA, CANADA
1
0
0
0
Stock Option (Right to Buy)
7.00
2020-12-11
4
A
0
25000
0.00
A
2030-12-11
Common Shares
25000
25000
D
25% of the options vest after 12 months from the date of grant, and the remaining 75% vest in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting on every one month anniversary thereafter.
/s/ Richard Glickman
2021-01-11